2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride

We are 2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride CAS:5424-47-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: 2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride
CAS.NO:  5424-47-5
Synonyms:
3-(dimethylamino)-1-thiophen-2-ylpropan-1-one,hydrochloride

Molecular Formula: C9H14ClNOS
Molecular Weight:  219.73200

Physical and Chemical Properties:
Density: 1.096g / cm3
Boiling point: 282.6ºC at 760mmHg
Melting point: 176.0°C to 182.0 °C
Flash point: 124.7ºC

Specification:
Appearance:White Powder
Purity:≥98.0%
Partical size:100% Through 80 Mesh
Loss on Drying:≤5%
Total Heavy Metals:≤10ppm
Arsenic:≤2ppm
Hg:≤2ppm
Pesticides:≤2ppm
Total Plate Count:≤1000cfu/g
Total Yeast & Mold: ≤100cfu/g
Yeast&Mold:≤100cfu/g

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Keep in cool & dry place.Keep away from strong light and heat.
Application:Intermediates of Duloxetine hydrochloride CAS:136434-34-9.

2-[3-(Dimethylamino)propionyl]thiophene Hydrochloride


Related News: According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.(10-([1,1':3',1''-terphenyl]-5'-yl)anthracen-9-yl)boronic acid CAS:1415334-59-6 According to statistics, in the ten years from 2008 to 2017, a total of 13 “China Class 1” small-molecule chemical drugs were independently researched and developed by domestic enterprises in China and approved by the CFDA; in 2018, there were 10 varieties of domestic Class 1 new drugs. Approved for listing in China.1-bromo-2-nitrobenceno CAS:577-19-5 The foundational patent, which expires in 2034, is owned by MSK and is licensed exclusively to Fate Therapeutics for all human therapeutic uses.1168150-46-6 “We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”“We believe the iLet Bionics Pancreas System represents a true breakthrough therapy for the management of glycemia, particularly in type 1 diabetes,” said Ed Damiano, President and CEO of Beta Bionics. “We are partuclarly excited by the possibility that the iLet may be able to provide safer and more effective therapy in far more people than current therapies due to its simplicity of use.”

Related Products
Product Name
1-Bromo-2,5-difluorobenzene View Details
3′-O-methylguanosine View Details
4-(Difluoromethoxy)aniline View Details
isonicotinic acid manufacturer Hexamethyldisilane manufacturer 5-Fluoro-2-nitrobenzoic acid manufacturer Methyl 3-(cyclopropylmethoxy)-4-hydroxybenzoate manufacturer 4-(Trifluoromethoxy)benzyl alcohol manufacturer